{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:27:24Z","timestamp":1767706044625,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T00:00:00Z","timestamp":1480464000000},"content-version":"vor","delay-in-days":334,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2016]]},"DOI":"10.6061\/clinics\/2016(11)03","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T08:23:45Z","timestamp":1481617425000},"page":"635-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mortality reduction with use of oral beta-blockers in patients with acute coronary syndrome"],"prefix":"10.1016","volume":"71","author":[{"given":"Alexandre","family":"de Matos Soeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Gabriel Melo","family":"de Barros e Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Alberto","family":"de Castro Roque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline Siqueira","family":"Bossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindel Nogueira","family":"Zullino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila Aparecida","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Yumi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"de Carvalho Andreucci Torres Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carolina Feres","family":"de Almeida Soeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Carlos V.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"M\u00facio Tavares","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.6061\/clinics\/2016(11)03_bib1","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"issue":"25","key":"10.6061\/clinics\/2016(11)03_bib2","first-page":"e344","article-title":"2014 AHA\/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"issue":"10","key":"10.6061\/clinics\/2016(11)03_bib3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with \u03b2-blockers for myocardial infarction: a meta-analysis of randomized trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am J Med"},{"issue":"3","key":"10.6061\/clinics\/2016(11)03_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ahj.2010.06.023","article-title":"beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing","volume":"160","author":"Goldberger","year":"2010","journal-title":"Am Heart J"},{"issue":"19","key":"10.6061\/clinics\/2016(11)03_bib5","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.jacc.2013.04.102","article-title":"Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction","volume":"62","author":"Arnold","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.6061\/clinics\/2016(11)03_bib6","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0735-1097(94)00552-2","article-title":"Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice","volume":"25","author":"Viskin","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.6061\/clinics\/2016(11)03_bib7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jacc.2015.07.047","article-title":"Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction","volume":"66","author":"Goldberger","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.6061\/clinics\/2016(11)03_bib8","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/eurheartj\/ehm489","article-title":"Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials","volume":"28","author":"Cucherat","year":"2007","journal-title":"Eur Heart J"},{"issue":"9497","key":"10.6061\/clinics\/2016(11)03_bib9","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"issue":"13","key":"10.6061\/clinics\/2016(11)03_bib10","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jacc.2015.08.007","article-title":"Beta-Blocker Therapy After Myocardial Infarction: More Questions Than Answers","volume":"66","author":"Taqueti","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.6061\/clinics\/2016(11)03_bib11","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"8251","key":"10.6061\/clinics\/2016(11)03_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0140-6736(81)91101-6","article-title":"Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial","volume":"2","author":"Hjalmarson","year":"1981","journal-title":"Lancet"},{"issue":"9266","key":"10.6061\/clinics\/2016(11)03_bib13","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.6061\/clinics\/2016(11)03_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacc.2014.04.042","article-title":"\u03b2-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease","volume":"64","author":"Andersson","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.6061\/clinics\/2016(11)03_bib15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.resuscitation.2007.08.022","article-title":"Beta-blocker use and the changing epidemiology of out-of-hospital cardiac arrest rhythms","volume":"76","author":"Youngquist","year":"2008","journal-title":"Resuscitation"},{"issue":"7200","key":"10.6061\/clinics\/2016(11)03_bib16","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"beta Blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"issue":"8","key":"10.6061\/clinics\/2016(11)03_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199808203390801","article-title":"Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction","volume":"339","author":"Gottlieb","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"10.6061\/clinics\/2016(11)03_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.amjcard.2012.10.026","article-title":"Impact of beta blockade therapy on long-term mortality after ST-segment elevation acute myocardial infarction in the percutaneous coronary intervention era","volume":"111","author":"Nakatani","year":"2013","journal-title":"Am J Cardiol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222010328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222010328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:57:35Z","timestamp":1761721055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222010328"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322016001100635&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5108170\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"alternative-id":["S1807593222010328"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2016(11)03","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality reduction with use of oral beta-blockers in patients with acute coronary syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2016(11)03","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}